TMO

510.93

0.81% -4.19

Handel nachbörslich: 510.93

Thermo Fisher Scientific Inc (TMO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$515.12

Offen:

$510.69

24-Stunden-Volumen:

1.36M

Relative Volume:

0.64

Marktkapitalisierung:

$191.96B

Einnahmen:

$44.56B

Nettoeinkommen (Verlust:

$6.73B

KGV:

28.80

EPS:

17.7391

Netto-Cashflow:

$6.29B

1W Leistung:

+1.21%

1M Leistung:

-17.46%

6M Leistung:

+3.26%

1J Leistung:

-5.00%

1-Tages-Spanne:

$506.50

$514.88

1-Wochen-Bereich:

$498.16

$515.51

52-Wochen-Spanne:

$385.46

$643.99

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Firmenname

Thermo Fisher Scientific Inc

Sektor

Healthcare (1108)

Branche

Diagnostics & Research (53)

Telefon

(781) 622-1000

Adresse

168 THIRD AVENUE, WALTHAM, MA

Mitarbeiter

125,000

Twitter

@thermofisher

Nächster Verdiensttermin

2026-01-29

Neueste SEC-Einreichungen

TMO's Discussions on Twitter

Compare TMO vs DHR, IDXX, A, WAT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMO Thermo Fisher Scientific Inc	510.93	193.53B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	209.50	149.33B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	635.66	50.36B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	122.90	35.73B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	333.33	32.24B	3.17B	642.63M	539.81M	10.77

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-11	Hochstufung	Citigroup	Neutral → Buy
2025-12-09	Eingeleitet	Goldman	Buy
2025-12-08	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	Fortgesetzt	Morgan Stanley	Overweight
2025-12-01	Hochstufung	HSBC Securities	Hold → Buy
2025-09-11	Hochstufung	Barclays	Equal Weight → Overweight
2025-08-19	Eingeleitet	William Blair	Outperform
2025-07-24	Herabstufung	HSBC Securities	Buy → Hold
2025-07-11	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Herabstufung	UBS	Buy → Neutral
2025-01-10	Hochstufung	Bernstein	Mkt Perform → Outperform
2024-12-23	Eingeleitet	Scotiabank	Sector Perform
2024-10-14	Eingeleitet	Redburn Atlantic	Buy
2024-10-01	Eingeleitet	Stephens	Overweight
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-03	Fortgesetzt	Jefferies	Buy
2024-03-18	Fortgesetzt	Citigroup	Neutral
2024-01-24	Herabstufung	Barclays	Overweight → Equal Weight
2024-01-08	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-10-26	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-06	Fortgesetzt	Citigroup	Buy
2023-07-19	Eingeleitet	Raymond James	Outperform
2023-07-19	Bestätigt	Robert W. Baird	Outperform
2023-07-13	Hochstufung	Credit Suisse	Neutral → Outperform
2023-04-04	Bestätigt	Barclays	Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-25	Eingeleitet	Credit Suisse	Neutral
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-26	Fortgesetzt	Barclays	Overweight
2021-10-20	Hochstufung	Citigroup	Neutral → Buy
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-16	Eingeleitet	The Benchmark Company	Buy
2021-03-18	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Eingeleitet	Barclays	Overweight
2021-01-08	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-12-02	Eingeleitet	Goldman	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-09-14	Eingeleitet	Morgan Stanley	Overweight
2020-08-20	Fortgesetzt	JP Morgan	Overweight
2020-07-15	Hochstufung	Cleveland Research	Neutral → Buy
2020-07-07	Bestätigt	Needham	Buy
2020-04-23	Bestätigt	Needham	Buy
2020-01-31	Bestätigt	Needham	Buy
2020-01-22	Eingeleitet	Credit Suisse	Neutral
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-25	Bestätigt	Needham	Buy
2019-07-16	Herabstufung	Needham	Strong Buy → Buy
2019-05-30	Eingeleitet	Wolfe Research	Outperform
2019-05-23	Bestätigt	Needham	Strong Buy
2019-04-22	Bestätigt	Needham	Strong Buy
2019-04-16	Bestätigt	BofA/Merrill	Buy

Alle ansehen

Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten

05:58 AM

Thermo Fisher Microscopes: The Lab Upgrade US Scientists Are Racing To Get - AD HOC NEWS

05:58 AM

09:34 AM

Cell Culture Pcr Plate Market Is Going to Boom Rapidly With Top Key - openPR.com

09:34 AM

08:14 AM

ICICI Prudential Asset Management Co Ltd Buys 6,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

08:14 AM

06:28 AM

China Universal Asset Management Co. Ltd. Invests $1.92 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat

06:28 AM

05:58 AM

Factory Mutual Insurance Co. Increases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

05:58 AM

05:43 AM

CenterBook Partners LP Raises Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

05:43 AM

Fiera Capital Corp Has $73.42 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

05:43 AM

05:12 AM

Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading - Yahoo Finance

05:12 AM

Feb 19, 2026

Is Thermo Fisher’s Datavant Deal and Clario Financing Altering The Investment Case For TMO? - simplywall.st

Feb 19, 2026

Ontario Teachers Pension Plan Board Purchases New Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Feb 19, 2026

King Luther Capital Management Corp Has $329.87 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Feb 19, 2026

3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players - Yahoo Finance

Feb 19, 2026

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance

Feb 19, 2026

Liquid Handling System Market Is Going to Boom | Thermo Fisher Scientific • Eppendorf AG • Sartorius AG • Gilson Inc - openPR.com

Feb 19, 2026

Can Thermo Fisher Scientific Stock Recover If Markets Fall? - Trefis

Feb 19, 2026

Feb 18, 2026

Michael Hakes' Top Picks: Nu Holdings, Thermo Fisher Scientific & Amazon.com - BNN Bloomberg

Feb 18, 2026

Thermo Fisher boosts connected planning with Oracle Cloud EPM - Oracle

Feb 18, 2026

Thermo Fisher Launches Kit for Sequential Protein, DNA and RNA Extraction - Contract Pharma

Feb 18, 2026

Clinical Trials Support Software Solutions in a $34.15B Trial Economy by 2035 - GlobeNewswire Inc.

Feb 18, 2026

Food Safety Testing Market to Reach US$40.1 Billion by 2029 - openPR.com

Feb 18, 2026

Axxcess Wealth Management LLC Purchases 2,374 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Feb 18, 2026

DNA Sequencing Market Is Booming So Rapidly by 2033 | Thermo Fisher Scientific, Inc., Illumina - openPR.com

Feb 18, 2026

DNA RNA Banking Services Market Is Going to Boom | Thermo Fisher Scientific • Illumina • 23andMe • AncestryDNA - openPR.com

Feb 18, 2026

Thermo Fisher confirms agreement to buy Solventum filtration unit (update) - MSN

Feb 18, 2026

Is Thermo Fisher Scientific Inc. currently under institutional pressure2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru

Feb 18, 2026

Feb 17, 2026

Thermo Fisher stock steadies near $504 as Danaher’s $9.9 billion Masimo deal rattles life-sciences names - Bez Kabli

Feb 17, 2026

QXO, Apollo Global, Thermo Fisher Scientific And More On CNBC's 'Final Trades' - Benzinga

Feb 17, 2026